Breaking News Instant updates and real-time market news.

2020-10-02 12:18:58 KGFHY Kingfisher $0.00 / + (+0.00%) 12:18 10/02/20 10/02 12:18 10/02/20 12:18	Kingfisher price target raised to 375 GBp from 335 GBp at RBC Capital RBC Capital analyst Richard Chamberlain raised the firm's price target on Kingfisher to 375 GBp from 335 GBp and keeps an Outperform rating on the shares.
KGFHY Kingfisher $0.00 / + (+0.00%) 10/02/20 Goldman Sachs Kingfisher price target raised to 330 GBp from 320 GBp at Goldman Sachs 09/30/20 Citi Kingfisher price target raised to 270 GBp at Citi 09/23/20 Morgan Stanley Kingfisher price target raised to 340 GBp from 320 GBp at Morgan Stanley 09/04/20 Exane BNP Paribas Kingfisher upgraded to Outperform from Neutral at Exane BNP Paribas

2020-10-02 12:18:58

KGFHY

Kingfisher

$0.00 / + (+0.00%)

12:18

10/02/20

10/02

12:18

10/02/20

12:18

Kingfisher price target raised to 375 GBp from 335 GBp at RBC Capital

RBC Capital analyst Richard Chamberlain raised the firm's price target on Kingfisher to 375 GBp from 335 GBp and keeps an Outperform rating on the shares.

KGFHY Kingfisher

$0.00 / + (+0.00%)

10/02/20 Goldman Sachs: Kingfisher price target raised to 330 GBp from 320 GBp at Goldman Sachs

09/30/20 Citi: Kingfisher price target raised to 270 GBp at Citi

09/23/20 Morgan Stanley: Kingfisher price target raised to 340 GBp from 320 GBp at Morgan Stanley

09/04/20 Exane BNP Paribas: Kingfisher upgraded to Outperform from Neutral at Exane BNP Paribas

TODAY'S FREE FLY STORIES

Hot Stocks	ENGlobal updates progress on modular hydrogen plant, Green Energy » 08:19 01/20/21 01/20 08:19 01/20/21 08:19 ENG ENGlobal $7.73 / +0.86 (+12.52%) ENGlobal issued a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News ENG ENGlobal $7.73 / +0.86 (+12.52%) 12/07/20 ENGlobal regains Nasdaq compliance
Hot Stocks	Enzo Biochem board forms corporate development, planning & succession committees » 08:16 01/20/21 01/20 08:16 01/20/21 08:16 ENZ Enzo Biochem $3.20 / +0.17 (+5.61%) Enzo Biochem announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings On The Fly Options ENZ Enzo Biochem $3.20 / +0.17 (+5.61%) 01/04/21 Harbert says Enzo refused to disclose preliminary shareholder votes 01/04/21 Enzo Biochem receives FDA EUA for testing pooled samples 12/31/20 Roumell says ISS, Glass Lewis recommend vote against Enzo chairman 12/28/20 Enzo Biochem CEO requests bonus to be paid in common stock after ISS report ENZ Enzo Biochem $3.20 / +0.17 (+5.61%) 11/17/20 Enzo Biochem sees Q1 revenue up 'at least 40%' from Q4, two board members resign ENZ Enzo Biochem $3.20 / +0.17 (+5.61%) 11/17/20 Fly Intel: Pre-market Movers ENZ Enzo Biochem $3.20 / +0.17 (+5.61%) 10/13/20 Enzo Biochem options imply 18.6% move in share price post-earnings
Initiation	Morgan Stanley starts Polaris at Overweight with $140 price target » 08:16 01/20/21 01/20 08:16 01/20/21 08:16 PII Polaris $113.25 / +5.25 (+4.86%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PII Polaris $113.25 / +5.25 (+4.86%) 12/22/20 Polaris appoints Michael Speetzen interim CEO 11/18/20 Polaris falls -6.6% 11/17/20 Polaris CEO Scott Wine to leave to assume CEO role at CNH Industrial 11/17/20 CNH Industrial names Scott W. Wine CEO PII Polaris $113.25 / +5.25 (+4.86%) 05:39 Today BMO Capital Polaris upgraded to Outperform from Market Perform at BMO Capital 01/19/21 Morgan Stanley Polaris initiated with an Overweight at Morgan Stanley 01/19/21 Wedbush Polaris price target raised to $126 from $116 at Wedbush 01/05/21 Baird Polaris added to 2021 Best Idea list at Baird PII Polaris $113.25 / +5.25 (+4.86%) 11/17/20 Polaris backs FY20 adjusted EPS view $7.15-$7.30, consensus $7.28 10/27/20 Polaris sees Q4 revenue growing sequentially, consensus $1.95B 10/27/20 Polaris raises FY20 adj. EPS view to $7.15-$7.30 from $6.40-$6.60 10/27/20 Polaris reports Q3 EPS $2.66, consensus $2.19 PII Polaris $113.25 / +5.25 (+4.86%) 11/17/20 Fly Intel: After-Hours Movers 07/28/20 Fly Intel: Pre-market Movers 01/26/21 Polaris - PII
Recommendations	Green Thumb Industries price target raised to $40 from $29 at Roth Capital » 08:15 01/20/21 01/20 08:15 01/20/21 08:15 GTBIF Green Thumb Industries $0.00 / + (+0.00%) Roth Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events GTBIF Green Thumb Industries $0.00 / + (+0.00%) 12/31/20 Green Thumb announces resignation of board member Alex Yemenidjian 11/12/20 Green Thumb Industries CEO says cannabis market similar to online gaming 11/12/20 Green Thumb CEO sees cannabis growing 20% annually for next decade 11/11/20 Green Thumb Industries to open Rise Kendall in Florida GTBIF Green Thumb Industries $0.00 / + (+0.00%) 01/19/21 Needham Green Thumb Industries price target raised to $46.75 from $39 at Needham 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 11/12/20 Stifel Green Thumb Industries price target raised to C$46 from C$44 at Stifel 11/12/20 Canaccord Green Thumb Industries price target raised to C$34 from C$27 at Canaccord GTBIF Green Thumb Industries $0.00 / + (+0.00%) 11/12/20 Rising High: Cannabis companies report earnings 09/03/20 Rising High: Cannabis firms report second quarter earnings 03/15/21 33rd Annual Roth Virtual Conference
Hot Stocks	TypTap receives approval to write homeowners insurance in Michigan » 08:15 01/20/21 01/20 08:15 01/20/21 08:15 HCI HCI Group $54.24 / +0.015 (+0.03%) TypTap Insurance Company… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings HCI HCI Group $54.24 / +0.015 (+0.03%) 01/12/21 TypTap receives approval to write homeowners insurance in Nevada 12/17/20 HCI Group to acquire insurance business in four states from United Insurance 12/17/20 United Insurance to transfer personal lines business in four states to HCI Group 10/23/20 HCI Group issues Q3 CAT loss estimate of $17.7M related to Hurricane Sally HCI HCI Group $54.24 / +0.015 (+0.03%) 06/02/20 JMP Securities HCI Group price target raised to $55 from $50 at JMP Securities HCI HCI Group $54.24 / +0.015 (+0.03%) 11/05/20 HCI Group reports Q3 EPS $1.60, consensus (10c) 08/06/20 HCI Group CEO expects growth to accelerate in coming years 08/06/20 HCI Group reports Q2 adjusted EPS 86c, consensus 46c

Downgrade	Senseonics downgraded to Sell at Craig-Hallum » 08:13 01/20/21 01/20 08:13 01/20/21 08:13 SENS Senseonics $2.78 / +1.2 (+76.19%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options SENS Senseonics $2.78 / +1.2 (+76.19%) 01/19/21 Senseonics announces positive coverage decision for Eversense CGM 10/05/20 Senseonics submits PMA application for 180-Day Eversense System to the FDA 08/10/20 Senseonics to partner with Ascensia Diabetes Care 08/07/20 Senseonics announces Highmark coverage for Eversense CGM to begin in September SENS Senseonics $2.78 / +1.2 (+76.19%) 07:14 Today Craig-Hallum Senseonics downgraded to Sell from Hold at Craig-Hallum 12/24/20 BTIG Senseonics approval delay 'disappointing but understandable,' says BTIG 08/11/20 Craig-Hallum Senseonics upgraded to Hold at Craig-Hallum following Ascensia partnership 08/11/20 Craig-Hallum Senseonics upgraded to Hold from Sell at Craig-Hallum SENS Senseonics $2.78 / +1.2 (+76.19%) 12/23/20 Senseonics sees FY21 revenue $12M-$15M, consensus $12.7M 12/23/20 Senseonics sees Q4 revenue $3.5M, consensus $2.49M 11/09/20 Senseonics reports Q3 EPS (10c), consensus (6c) 08/10/20 Senseonics reports Q2 EPS (3c), consensus (9c) SENS Senseonics $2.78 / +1.2 (+76.19%) 12/24/20 Fly Intel: Pre-market Movers SENS Senseonics $2.78 / +1.2 (+76.19%) 01/06/21 Largest borrow rate increases among liquid names 12/24/20 Unusually active option classes on open December 24th
Hot Stocks	Osisko Gold appoints Candace MacGibbon to board of directors » 08:12 01/20/21 01/20 08:12 01/20/21 08:12 OR Osisko Gold $11.84 / +0.015 (+0.13%) , ILNLF INV Metals $0.00 / + (+0.00%) Osisko Gold Royalties… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings OR OR Osisko Gold $11.84 / +0.015 (+0.13%) 01/13/21 Osisko Gold appoints Heather Taylor to VP, investor relations 10/29/20 Osisko Gold, Barolo Ventures complete C$100M subscription receipt offering 10/13/20 Osisko Gold signs agreement with Lhtako Dene Nation for Cariboo Gold Project 10/05/20 Osisko Gold announces spin-out of mining assets, concurrent bought deal offering OR ILNLF OR Osisko Gold $11.84 / +0.015 (+0.13%) 01/11/21 National Bank Osisko Gold price target raised to C$23.50 from C$23 at National Bank 01/11/21 Scotiabank Osisko Gold price target raised to C$25 from C$24 at Scotiabank 12/02/20 Raymond James Osisko Gold price target raised to C$21.50 from C$20 at Raymond James 11/11/20 CIBC Osisko Gold upgraded to Outperformer from Neutral at CIBC ILNLF INV Metals $0.00 / + (+0.00%) 01/15/21 Raymond James INV Metals price target lowered to C$1.50 from C$1.75 at Raymond James OR OR Osisko Gold $11.84 / +0.015 (+0.13%) 01/13/21 Osisko Gold reports Q4 preliminary revenues C$64.5M 10/20/20 Osisko Gold reports preliminary Q3 revenues C$55.7M, consensus C$59.25M
Hot Stocks	Hall of Fame Resort and Entertainment Company and Tupelo Honey in partnership » 08:11 01/20/21 01/20 08:11 01/20/21 08:11 HOFV Hall of Fame Resort & Entertainment $1.86 / +0.06 (+3.33%) , GTN Gray Television $16.97 / -0.09 (-0.53%) Hall of Fame Resort &… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals HOFV GTN HOFV Hall of Fame Resort & Entertainment $1.86 / +0.06 (+3.33%) 12/15/20 Hall of Fame Resort & Entertainment partners with StakeKings in 'fantasy' league 12/02/20 Hall of Fame Resort & Entertainment jumps almost 4% after securing loan 11/20/20 Hall of Fame Resort & Entertainment enter partnership with Republic Services 08/27/20 Hall of Fame Resort & Entertainment appoints Tara Charnes as General Counsel GTN Gray Television $16.97 / -0.09 (-0.53%) 12/28/20 Mediacom enters new carriage agreement with Gray Television 12/16/20 Gray Television surpasses $400M in net political advertising revenue for 2020 12/07/20 Gray Television announces launch of first NexGen TV station 12/07/20 Comscore announces renewal, expansion agreement with Gray Television HOFV GTN HOFV Hall of Fame Resort & Entertainment $1.86 / +0.06 (+3.33%) 12/15/20 Maxim Hall of Fame Resort & Entertainment initiated with a Buy at Maxim GTN Gray Television $16.97 / -0.09 (-0.53%) 01/05/21 Benchmark GM, Roku, Marcus among Benchmark's Best Ideas for first half of 2021 01/05/21 Loop Capital Gray Television price target raised to $25 from $23 at Loop Capital 10/15/20 Loop Capital Gray Television initiated with a Buy at Loop Capital 10/14/20 Loop Capital Gray Television initiated with a Buy at Loop Capital GTN GTN Gray Television $16.97 / -0.09 (-0.53%) 11/05/20 Gray Television reports Q3 EPS $1.14, consensus 89c 10/08/20 Gray Television not providing 2020 guidance, sees being free cash flow positive 10/08/20 Gray Television sees Q3 revenue ex-commissions $590M-$600M, consensus $546.43M 08/06/20 Gray Television reports Q2 EPS (2c), consensus 3c GTN GTN Gray Television $16.97 / -0.09 (-0.53%) 10/02/20 Supreme Court to hear FCC push to ease media ownership rules, Reuters reports 07/21/20 Tegna suitors still interested in deal, Dealreporter says
Hot Stocks	Equus shareholders grant authorization to withdraw BDC election » 08:09 01/20/21 01/20 08:09 01/20/21 08:09 EQS Equus II Inc $1.60 / -0.08 (-4.76%) Equus Total Return… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News EQS Equus II Inc $1.60 / -0.08 (-4.76%) 01/04/21 UFP Industries gets initial payment from sale of interest in PalletOne 12/10/20 Equus II Inc announces pending sale of PalletOne equity for $232M 11/17/20 Equus Total Return reports net asset value of $2.77 as of Sept. 30
Hot Stocks	Capstone Turbine receives order for 600 kW Signature Series microturbine » 08:09 01/20/21 01/20 08:09 01/20/21 08:09 CPST Capstone Turbine $12.05 / +0.085 (+0.71%) Capstone Turbine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options CPST Capstone Turbine $12.05 / +0.085 (+0.71%) 01/11/21 Capstone Turbine announces several orders for eight C65 microturbines 12/29/20 Capstone Turbine announces 10% ITC extended through 2023 in stimulus package 12/22/20 Capstone Turbine gets follow-on order from latex-based manufacturer 12/16/20 Capstone Turbine announces Horizon Power Systems renews FPP service pact CPST Capstone Turbine $12.05 / +0.085 (+0.71%) 01/07/21 Craig-Hallum Capstone Turbine price target raised to $13 from $6 at Craig-Hallum 11/11/20 Lake Street Capstone Turbine price target raised to $7 from $5 at Lake Street 06/30/20 Maxim Capstone Turbine downgraded to Hold from Buy at Maxim CPST Capstone Turbine $12.05 / +0.085 (+0.71%) 01/06/21 Capstone Turbine reports preliminary Q3 revenue $20.6M, consensus $16.42M 08/07/20 Capstone Turbine reports Q1 EPS (17c), consensus (21c) CPST Capstone Turbine $12.05 / +0.085 (+0.71%) 01/02/21 Week in review: How Trump's policies moved stocks 02/09/21 Capstone Turbine - CPST CPST Capstone Turbine $12.05 / +0.085 (+0.71%) 01/06/21 Fifteen new option listings on January 6th

Hot Stocks	DZS acquires Optelian, terms not disclosed » 08:08 01/20/21 01/20 08:08 01/20/21 08:08 DZSI DZS $16.98 / -0.03 (-0.18%) DZS announced it has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Options DZSI DZS $16.98 / -0.03 (-0.18%) 01/04/21 DZS appoints Matt Bross, Barbara Carbone to board of directors 10/22/20 DZS pulls forward earnings release, conference call 10/06/20 DZS names Andrew Bender as CTO, Darrin Whitney as CIO 09/17/20 Dasan Zhone, Tektraco Telecom collaborate on gigabit-ready hotels and facilities DZSI DZS $16.98 / -0.03 (-0.18%) 01/11/21 B. Riley Securities DZS price target raised to $20 from $15 at B. Riley Securities 01/04/21 Craig-Hallum DZS price target raised to $24 from $18 at Craig-Hallum 11/02/20 B. Riley Securities DZS price target raised to $15 from $14 at B. Riley Securities 07/09/20 B. Riley FBR EXFO results positive for Viavi and Dasan, says B. Riley FBR DZSI DZS $16.98 / -0.03 (-0.18%) 10/29/20 DZS sees Q4 revenue $75M-$80M, consensus $85.61M 10/29/20 DZS reports Q3 EPS 20c, consensus 3c 08/05/20 Dasan Zhone reports Q2 EPS 9c, consensus (14c) DZSI DZS $16.98 / -0.03 (-0.18%) 01/06/21 Fifteen new option listings on January 6th
Initiation	Genius Sports initiated with a Buy at Craig-Hallum » 08:07 01/20/21 01/20 08:07 01/20/21 08:07 DMYD dMY Technology II $16.79 / -0.6501 (-3.73%) Craig-Hallum analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News On The Fly DMYD dMY Technology II $16.79 / -0.6501 (-3.73%) 12/09/20 dMY Technology II rises 15.9% 10/27/20 Genius Sports to become public company through dMY Technology II combination DMYD dMY Technology II $16.79 / -0.6501 (-3.73%) 10/27/20 Fly Intel: Pre-market Movers
Syndicate	Lithium Americas 15.9M share Spot Secondary priced at $22.00 » 08:06 01/20/21 01/20 08:06 01/20/21 08:06 LAC Lithium Americas $26.80 / +6.27 (+30.54%) The deal size was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options LAC Lithium Americas $26.80 / +6.27 (+30.54%) 07:50 Today Lithium Americas trading halted, news pending 01/19/21 Lithium Americas rises 30.6% 01/19/21 Lithium Americas rises 19.6% 01/19/21 Lithium Americas rises 15.7% LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/06/21 Canaccord Lithium Americas price target raised to C$20 from C$11.50 at Canaccord 12/23/20 Stifel Stifel starts Lithium Americas with Buy, sees 'attractive upside' 12/22/20 Stifel Lithium Americas initiated with a Buy at Stifel 10/21/20 Roth Capital Lithium Americas downgraded to Neutral from Buy at Roth Capital LAC Lithium Americas $26.80 / +6.27 (+30.54%) 08/14/20 Lithium Americas reports Q2 EPS (7c) vs. (7c) last year 20 Jan LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/19/21 Fly Intel: After-Hours Movers 12/22/20 Fly Intel: After-Hours Movers 09/23/20 Tesla, lithium names under pressure as Wall Street digests Battery Day LAC Lithium Americas $26.80 / +6.27 (+30.54%) 01/13/21 Lithium Americas call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd 12/22/20 Lithium Americas call volume above normal and directionally bullish 12/18/20 Largest borrow rate increases among liquid names
Hot Stocks	Ocular Therapeutix to present new OTX-TIC data at Glaucoma 360 Forum » 08:06 01/20/21 01/20 08:06 01/20/21 08:06 OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) Ocular Therapeutix… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 12/22/20 Ocular Therapeutix submits Dextenza sNDA to FDA 11/04/20 Ocular Therapeutix receives permanent category I CPT code from AMA 10/30/20 Ocular Therapeutix announces Dextenza, OTX-TIC license agreement with AffaMed 10/13/20 Ocular Therapeutix reaches agreement w/ FDA on ReSure retrospective study OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 12/30/20 JMP Securities Ocular Therapeutix price target raised to $30 from $20 at JMP Securities 12/28/20 Fly Intel: Top five analyst calls 12/28/20 H.C. Wainwright Ocular Therapeutix downgraded to Neutral from Buy at H.C. Wainwright 12/21/20 Piper Sandler Ocular Therapeutix price target raised to $28 from $16 at Piper Sandler OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 11/05/20 Ocular Therapeutix reports Q3 EPS (21c), consensus (24c) 10/07/20 Ocular Therapeutix reports preliminary Q3 revenue $5.8M-$5.9M, consensus $3.91M 08/07/20 Ocular Therapeutix reports Q2 EPS (64c), consensus (31c) 16 Dec 14 Oct 20 May OCUL Ocular Therapeutix $20.05 / -0.24 (-1.18%) 12/28/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: Pre-market Movers 12/14/20 Fly Intel: After-Hours Movers 10/13/20 Fly Intel: After-Hours Movers
Earnings	EDAP TMS reports preliminary 2020 revenue EUR41.6M vs. EUR44.9M last year 08:06 01/20/21 01/20 08:06 01/20/21 08:06 EDAP EDAP TMS $6.81 / +0.14 (+2.10%) ShowHide Related Items >><< Company News Street Research Earnings EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/14/21 EDAP TMS announces 24 month interim results of AFU sponsored study 01/06/21 EDAP TMS CEO says sales pipeline continues to grow entering 2021 12/30/20 EDAP TMS announces two Focal One sales to healthcare institutions 12/09/20 EDAP TMS announces final U.S. 2021 reimbursement rules for HIFU EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/12/21 B. Riley Securities EDAP TMS price target raised to $11.50 from $5.50 at B. Riley Securities 04/15/20 Fly Intel: Top five analyst initiations 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 08:05 Today EDAP TMS reports preliminary Q4 revenue EUR15.3M vs. EUR12M last year 08/26/20 EDAP TMS reports Q2 EPS (EUR0.01) vs. EUR0.05 a year ago

Hot Stocks	CSG names Channing Martin Jones chief diversity, social responsibility officer » 08:05 01/20/21 01/20 08:05 01/20/21 08:05 CSGS CSG $44.40 / +1.2 (+2.78%) CSG announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CSGS CSG $44.40 / +1.2 (+2.78%) 12/01/20 CSG extends partnership with Airtel Africa 11/04/20 CSG expands relationship with Inmarsat 09/29/20 CSG's Forte Payment System in strategic pact with Accela 08/31/20 CSG CEO Bret Griess to step down, Brian Shepherd named CEO CSGS CSG $44.40 / +1.2 (+2.78%) 09/10/20 B. Riley FBR CSG pullback brings attractive entry point, says B. Riley FBR 03/10/20 Sidoti CSG upgraded to Buy from Neutral at Sidoti CSGS CSG $44.40 / +1.2 (+2.78%) 11/04/20 CSG backs FY20 EPS view of $2.87-$3.10, two estimates $3.02 11/04/20 CSG reports Q3 EPS 76c, two estimates 79c 08/05/20 CSG backs FY20 EPS view of $.287-$3.10, consensus $3.05 08/05/20 CSG reports Q2 EPS 59c, consensus 70c 02/03/21 CSG - CSGS
Recommendations	Netflix price target raised to $650 from $610 at Jefferies » 08:05 01/20/21 01/20 08:05 01/20/21 08:05 NFLX Netflix $501.85 / +3.9 (+0.78%) Jefferies analyst Alex… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $501.85 / +3.9 (+0.78%) 08:04 Today Barclays Netflix price target raised to $650 from $550 at Barclays 07:52 Today Monness Crespi Netflix price target raised to $650 from $600 at Monness Crespi 07:31 Today Canaccord Netflix price target raised to $670 from $630 at Canaccord 07:26 Today Deutsche Bank Netflix price target raised to $600 from $580 at Deutsche Bank NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $501.85 / +3.9 (+0.78%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st
Earnings	EDAP TMS reports preliminary Q4 revenue EUR15.3M vs. EUR12M last year » 08:05 01/20/21 01/20 08:05 01/20/21 08:05 EDAP EDAP TMS $6.81 / +0.14 (+2.10%) Marc Oczachowski,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/14/21 EDAP TMS announces 24 month interim results of AFU sponsored study 01/06/21 EDAP TMS CEO says sales pipeline continues to grow entering 2021 12/30/20 EDAP TMS announces two Focal One sales to healthcare institutions 12/09/20 EDAP TMS announces final U.S. 2021 reimbursement rules for HIFU EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 01/12/21 B. Riley Securities EDAP TMS price target raised to $11.50 from $5.50 at B. Riley Securities 04/15/20 Fly Intel: Top five analyst initiations 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR 04/15/20 B. Riley FBR EDAP TMS initiated with a Buy at B. Riley FBR EDAP EDAP TMS $6.81 / +0.14 (+2.10%) 08/26/20 EDAP TMS reports Q2 EPS (EUR0.01) vs. EUR0.05 a year ago
Recommendations	Netflix price target raised to $650 from $550 at Barclays » 08:04 01/20/21 01/20 08:04 01/20/21 08:04 NFLX Netflix $501.85 / +3.9 (+0.78%) Barclays analyst Kannan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix says 'super proud' of free cash flow 01/19/21 Netflix says not necessarily through the 'pull forward' of 2020 01/19/21 Netflix says past year 'testament' to company's approach 01/19/21 Netflix says 'very close to being sustainably FCF positive' NFLX Netflix $501.85 / +3.9 (+0.78%) 07:52 Today Monness Crespi Netflix price target raised to $650 from $600 at Monness Crespi 07:31 Today Canaccord Netflix price target raised to $670 from $630 at Canaccord 07:26 Today Deutsche Bank Netflix price target raised to $600 from $580 at Deutsche Bank 07:23 Today Cowen Netflix price target raised to $675 from $650 at Cowen NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix sees Q1 EPS $2.97, consensus $2.10 01/19/21 Netflix reports Q4 EPS $1.19, consensus $1.39 01/19/21 Notable companies reporting after market close 10/20/20 Netflix sees Q4 EPS $1.35, consensus 94c NFLX Netflix $501.85 / +3.9 (+0.78%) 01/15/21 Data suggests Netflix North American usage dipped in Q4, Business Insider says 01/06/21 Netflix raising prices for some UK subscription plans, BBC reports 12/15/20 Netflix streaming experiences outage for over 1,000 users, Reuters says 12/07/20 Netflix sued by Activision over allegedly poaching former CFO, WSJ reports NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Fly Intel: After-Hours Movers 01/19/21 Fly Intel: What to watch in Netflix earnings report 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street NFLX Netflix $501.85 / +3.9 (+0.78%) 01/19/21 Netflix options imply 9.5% move in share price post-earnings 12/31/20 Early notable gainers among liquid option names on December 31st 10/26/20 Early notable gainers among liquid option names on October 26th 10/21/20 Notable open interest changes for October 21st
Hot Stocks	Clarivate Analytics changing ticker symbol to "CLVT" February 1 » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) Clarivate's ticker… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) 11/30/20 Clarivate Analytics acquires Hanlim IPS 11/09/20 Clarivate Analytics divests Techstreet to ASME 09/01/20 Clarivate Analytics enters partnership with IP DESK 08/27/20 Clarivate Analytics appoints Stefano Maestri as Chief Technology Officer CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) 10/15/20 Goldman Sachs Clarivate Analytics reinstated with a Buy at Goldman Sachs 10/14/20 Morgan Stanley Clarivate Analytics initiated with an Equal Weight at Morgan Stanley 10/02/20 Barclays Clarivate Analytics price target raised to $35 from $26 at Barclays 08/04/20 Citi Clarivate Analytics price target raised to $33 from $28 at Citi CCC Clarivate Analytics $29.28 / -0.135 (-0.46%) 11/25/20 Clarivate Analytics raises 2020 adjusted EPS view to 55c-61c from 53c-59c 11/25/20 Clarivate Analytics sees 2021 adjusted EPS 73c-79c, consensus 78c 10/29/20 Clarivate Analytics raises FY20 adj. EPS view to 55c-61c from 53c-59c 10/29/20 Clarivate Analytics reports Q3 adj. EPS 14c, consensus 15c 04 Jun 06 Feb 02/25/21 Clarivate Analytics - CCC

Downgrade	Healthcare Trust downgraded to Equalweight from Overweight at Capital One » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 HTA Healthcare Trust $28.21 / -0.365 (-1.28%) Capital One downgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings HTA Healthcare Trust $28.21 / -0.365 (-1.28%) 01/12/21 Healthcare Trust reports acquisition of $129M of medical office investments 09/22/20 Healthcare Trust reactivates share repurchase program HTA Healthcare Trust $28.21 / -0.365 (-1.28%) 01/13/21 Jefferies Healthcare Trust price target raised to $35 from $33 at Jefferies 01/13/21 Jefferies Healthcare Realty Trust upgraded to Buy with sector 'unscathed' at Jefferies 12/21/20 JPMorgan JPMorgan changes ratings in REIT, Real Estate Services sectors into 2021 12/21/20 JPMorgan Healthcare Trust downgraded to Neutral from Overweight at JPMorgan HTA Healthcare Trust $28.21 / -0.365 (-1.28%) 11/03/20 Healthcare Trust reports Q3 normalized FFO 43c, consensus 42c 08/06/20 Healthcare Trust reports Q2 normalized FFO 42c, consensus 42c
Recommendations	Goldman Sachs price target raised to $335 from $320 at Wells Fargo » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 GS Goldman Sachs $294.20 / -6.85 (-2.28%) Wells Fargo analyst Mike… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/19/21 Goldman Sachs: Investment banking backlog at near-record levels 01/19/21 Goldman Sachs evaluating whether more staff can be moved to strategic locations 01/19/21 Goldman Sachs plans to resume share repurchases this quarter 01/19/21 Goldman Sachs plans to accelerate pace of asset sales GS Goldman Sachs $294.20 / -6.85 (-2.28%) 07:37 Today Oppenheimer Goldman Sachs price target raised to $445 from $407 at Oppenheimer 07:15 Today BMO Capital Goldman Sachs price target raised to $330 from $307 at BMO Capital 06:35 Today RBC Capital Goldman Sachs price target raised to $319 from $225 at RBC Capital 01/12/21 JMP Securities Goldman Sachs price target raised to $320 from $285 at JMP Securities GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/19/21 Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 01/18/21 Fly Intel: What to watch in next round of big banks' earnings reports 10/14/20 Goldman Sachs reports Q3 EPS $9.68, consensus $5.57 10/13/20 Notable companies reporting before tomorrow's open GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/07/21 Goldman Sachs CEO: 'I'd be cautious' of stock market volatility, Axios reports 12/31/20 M&A activity rebounded into year-end to finish 2020 down just 5%, FT says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/28/20 Goldman Sachs leads $65M financing in Echelon Fitness, Bloomberg says GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Technology & Internet Virtual Conference 02/24/21 22nd Annual Virtual Financial Services Forum 03/25/21 REITwise 2021 Virtual Conference GS Goldman Sachs $294.20 / -6.85 (-2.28%) 01/13/21 Unusual call flow in option market yesterday 01/12/21 Short term 300 strike calls in Goldman Sachs see early action 01/07/21 Goldman Sachs call volume above normal and directionally bullish 12/23/20 Unusually active option classes on open December 23rd
Hot Stocks	Seneca Biopharma reports data from Phase 2 study of NSI-566 in China » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 SNCA Seneca Biopharma $1.34 / + (+0.00%) Seneca Biopharma… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News SNCA Seneca Biopharma $1.34 / + (+0.00%) 01/13/21 Leading BioSciences announces Fast Track Designation for LB1148 01/08/21 Leading BioSciences announces topline data from gastrointestinal surgery study 12/17/20 Seneca Biopharma trading resumes 12/17/20 Seneca Biopharma, Leading BioSciences to merge in all-stock transaction
Hot Stocks	Gritstone, Genevant announce license agreement for COVID-19 vaccine » 08:03 01/20/21 01/20 08:03 01/20/21 08:03 GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) Gritstone Oncology and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) 01/19/21 Gritstone Oncology signs agreement with NIAID to begin testing COVID-19 vaccine 01/04/21 EcoR1 Capital reports 9.99% passive stake in Gritstone Oncology 12/28/20 Gritstone Oncology announces private placement financings totaling $125M 12/23/20 Gritstone Oncology announces $110M private placement GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) 06:25 Today H.C. Wainwright Gritstone Oncology price target raised to $24 from $16 at H.C. Wainwright 05:31 Today Baird Gritstone Oncology downgraded to Underperform from Outperform at Baird 07/14/20 BTIG Gritstone Oncology price target lowered to $17 from $31 at BTIG GRTS Gritstone Oncology $22.47 / +16.07 (+251.09%) 11/05/20 Gritstone Oncology reports Q3 EPS (69c), consensus (64c) 08/05/20 Gritstone Oncology reports Q2 EPS (69c), consensus (73c)
Hot Stocks	F-star Therapeutics receives european patent for FS118 molecule » 08:02 01/20/21 01/20 08:02 01/20/21 08:02 FSTX F-star Therapeutics $9.20 / +0.25 (+2.79%) F-star Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research FSTX F-star Therapeutics $9.20 / +0.25 (+2.79%) 01/04/21 F-star Therapeutics doses first patient in FS222 Phase 1 trial 12/03/20 F-star Therapeutics doses first patient in Phase 1 clinical trial of FS120 11/30/20 Glaxosmithkine reports 8.9% passive stake in F-star Therapeutics FSTX F-star Therapeutics $9.20 / +0.25 (+2.79%) 12/02/20 Ladenburg F-star Therapeutics initiated with a Buy at Ladenburg

Events

Earnings calls, analyst events, roadshows and more

MS
Today at 08:30

Morgan Stanley - MS Conference Calls
PG
Today at 08:30

Procter & Gamble - PG Conference Calls
UNH
Today at 08:45

UnitedHealth - UNH Conference Calls
Today at 08:55

Redbook Store Sales Y/Y: 1/16/21 Government Event
USB
Today at 09:00

U.S. Bancorp - USB Conference Calls
PNFP
Today at 09:30

Pinnacle Financial - PNFP Conference Calls
NJR
Today at 09:30

New Jersey Resources Corp Firm Sponsored Meetings
Today at 10:00

Housing Market Index: January 2021 Government Event
AG
Today at 10:00

First Majestic - AG Conference Calls
BOKF
Today at 10:00

BOK Financial - BOKF Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley $25.50-26.50 700K Shares ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright $17.00-18.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald $1.90-2.00 CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $64.18 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE $13.96 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush $12.00-15.00 9.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen $24.00-26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance $8.00-10.00 116.5M Shares ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities $26.55 4M Shares CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright $93.33 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler $8.48 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS $76.12 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel $28.61 5.5M Shares EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse $72.11 3.5M Shares MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink $24.71 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies $42.25 17.5M Shares CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen, & Stifel, Wedbush, Academy Securities $37.73 7.5M Shares PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan $29.05 7M Shares
Fri	No deals

View All Syndicate Announcements »

Kingfisher price target raised to 375 GBp from 335 GBp at RBC Capital

TODAY'S FREE FLY STORIES

Get Full Fly Access